Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits

Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.

Summary from the CNBC news feed. Copyright belongs to CNBC.

Read full story at CNBC ↗

Opens in a new tab, so Investz stays open.

ShareEmail X LinkedIn Facebook Reddit WhatsApp

Related on Investz

Walmart Inc. (WMT): live price and chart →

More headlines

All news

CNBCWilliams says Fed may not have to hike rates in 2027, at odds with traders CNBCS&P 500 is little changed as traders mull over bank earnings; chip stocks slide: Live updates CNBCApple releases HomeView smart home hub with screen as showcase for Siri AI CNBCPaul Tudor Jones says 2027 could be a really challenging year for the stock market CNBCBank earnings takeaways: Here's how JPMorgan, Goldman, Wells Fargo and Citi performed in Q3 CNBCMichael Dell says AI needs safeguards and controls, and government has a role to play

Headlines and summaries come from publishers’ public news feeds and are shown with attribution and a link to the original. Investz does not write or endorse them and they are not investment advice. Disclosures.